NBRV - Nabriva Therapeutics Plc (NBRV) CEO Ted Schroeder on Q2 2020 Results - Earnings Call Transcript
Nabriva Therapeutics Plc (NBRV)
Q2 2020 Earnings Conference Call
August 6, 2020 16:30 ET
Company Participants
Gary Sender - Chief Financial Officer
Ted Schroeder - Chief Executive Officer
Francesco Maria Lavino - Chief Commercial Officer
Jennifer Schranz - Chief Medical Officer
Steve Gelone - President & Chief Operating Officer
Conference Call Participants
Alan Carr - Needham & Company
Eduardo Arce - H.C. Wainwright & Co.
Kevin Kedra - G.Research
Presentation
Operator
Ladies and gentlemen, thank you for standing by. And welcome to the Nabriva Therapeutics Second Quarter 2020 Financial Results Call. At this time, all